Decision

Pfizer Limited v. Ratiopharm Inc., 2010 FCA 204

Justice Nadon; Justice Sharlow; Justice Layden-Stevenson - 2010-07-29

Read full decision. Automatically generated summary:

The respondent (Ratiopharm), pursuant to the provisions of the Patent Act, R.S.C. 1985, c. P.4 (the Act), commenced an action in the Federal Court with respect to the appellant’s (Pfizer) Canadian Letters Patent No. 1,321,393 (the '393 Patent). Ratiopharm requested, among other things, a declaration that the '393 Patent is invalid. A Federal Court judge (the trial judge) granted Ratiopharm’s request.

Decision relates to:

 

Canadian Intellectual Property